Novartis AG Current Assets
Novartis AG (NVSEF) had Current Assets of $30.46 billion as of 2025-12-31, per its 20-F filed 2026-02-04.
Financial Statements › Notes
ifrs-full:CurrentAssets · last filed 2026-02-04
- 2025-12-31: Current Assets $30.46B.
- 2025-06-30: Current Assets $25.94B.
- 2024-12-31: Current Assets $29.70B.
- 2024-06-30: Current Assets $25.69B.
| Period end | Current Assets |
|---|---|
| 2025-12-31 | $30.46B 20-F · filed 2026-02-04 |
| 2025-06-30 | $25.94B 6-K · filed 2025-07-17 |
| 2024-12-31 | $29.70B 20-F · filed 2026-02-04 |
| 2024-06-30 | $25.69B 6-K · filed 2024-07-18 |
| 2023-12-31 | $30.48B 20-F · filed 2025-01-31 |
| 2023-06-30 | $33.49B 6-K · filed 2023-07-18 |
| 2022-12-31 | $36.91B 20-F · filed 2024-01-31 |
| 2022-06-30 | $38.14B 6-K · filed 2022-07-19 |
| 2021-12-31 | $45.72B 20-F/A · filed 2023-05-15 |
| 2021-06-30 | $23.81B 6-K · filed 2021-07-21 |
| 2020-12-31 | $29.67B 20-F · filed 2022-02-02 |
| 2020-06-30 | $23.88B 6-K · filed 2020-07-21 |
| 2019-12-31 | $29.50B 20-F · filed 2021-01-26 |
| 2019-06-30 | $28.32B 6-K · filed 2019-07-18 |
| 2018-12-31 | $35.56B 20-F · filed 2020-01-29 |
| 2018-06-30 | $32.06B 6-K · filed 2018-07-18 |
| 2017-12-31 | $28.21B 20-F · filed 2019-01-30 |
| 2016-12-31 | $24.93B 6-K · filed 2018-01-24 |